510(k) · Cleared
Cleared40 CC Grande
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Boston Scientific Corp · DSP System, Balloon, Intra-Aortic And Control
Cleared on Feb 10, 1998 as substantially equivalent to K971673 (Boston Scientific Corp, 1997) and 4 other predicates after a 90-day review. Its family tree reaches back 3 generations to 1990.
- Decided
- Feb 10, 1998
- Review
- 90 days
- Class
- Class II
- Product code
- DSP
- Recalls
- None
- Predicates
- 5
Its longest line of descent runs back 3 generations to K892222 (1990). 8 ancestors in all. No later device cites it as a predicate yet.
- Root · 3 generations backK892222 9.5F Percu Double Lumen Intra-Aortic BalloonKontron Instruments, Inc. · 1990
- 2 generations backK963187 Modified Labeling of Cardiac Assist Intra-Aortic Balloon Catheters…Boston Scientific Corp · 1996
- 1 generation backK971673 40 CC SumoBoston Scientific Corp · 1997
- This deviceK974247 40 CC GrandeBoston Scientific Corp · 1998
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −3 | K892222 | 9.5F Percu Double Lumen Intra-Aortic Balloon | Kontron Instruments, Inc. | 1990 | — |
| −2 | K963187 | Modified Labeling of Cardiac Assist Intra-Aortic Balloon Catheters: Model 930… | Boston Scientific Corp | 1996 | — |
| −1 | K971673 | 40 CC Sumo | Boston Scientific Corp | 1997 | — |
| 0 (this device) | K974247 | 40 CC Grande | Boston Scientific Corp | 1998 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1991 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in DSP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new DSP device
- #1 K250542 AC3™ Range™ Intra-Aortic Balloon Pumpscore 11.2 · 8 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (7)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K971673 | 40 CC SumoSummary page 1…REDICATE DEVICE INFORMATION The following devices are referenced in this premarket notification as predicate devices for the 40 cc Grande™, subject of this submission: K971673: 40 cc SUMO for use on BSC/CA 3001, Datascope Systems 90 and 97, Kontron KAAT, St. Jude/Aries 700 and Bard H-8000. K963187: Modi… | 1997 |
| * | K963187 | Modified Labeling of Cardiac Assist Intra-Aortic Balloon Catheters: Model 930 - 940, 30…Summary page 1…e 40 cc Grande™, subject of this submission: K971673: 40 cc SUMO for use on BSC/CA 3001, Datascope Systems 90 and 97, Kontron KAAT, St. Jude/Aries 700 and Bard H-8000. K963187: Modified labeling of BSC/CA IAB’s. K954431: Modified Model 940 and Model 930 for use on BSC/CA 3001, [B):tgsfiope Systems 90 an… | 1996 |
| * | K954431 | Percutaneous Intra-Aortic Balloon CathetersSummary page 1…K971673: 40 cc SUMO for use on BSC/CA 3001, Datascope Systems 90 and 97, Kontron KAAT, St. Jude/Aries 700 and Bard H-8000. K963187: Modified labeling of BSC/CA IAB’s. K954431: Modified Model 940 and Model 930 for use on BSC/CA 3001, [B):tgsfiope Systems 90 and 97, Kontron KAAT, St. Jude/Aries 700 and rd… | 1996 |
| * | K952221 | BSC/CA 30 & 40 Sensation, Models 930 & 940Summary page 1…ling of BSC/CA IAB’s. K954431: Modified Model 940 and Model 930 for use on BSC/CA 3001, [B):tgsfiope Systems 90 and 97, Kontron KAAT, St. Jude/Aries 700 and rd H-8000. K952221: 30 cc and 40 cc Sensation™, Model 940 and Model 930 for use on Bard H-8000. K940298: Model 940 for use on BSC/CA 3001, Datascop… | 1995 |
| * | K940298 | BSC/CA Model 940 IabSummary page 1…1, [B):tgsfiope Systems 90 and 97, Kontron KAAT, St. Jude/Aries 700 and rd H-8000. K952221: 30 cc and 40 cc Sensation™, Model 940 and Model 930 for use on Bard H-8000. K940298: Model 940 for use on BSC/CA 3001, Datascope Systems 90 and 97, Kontron KAAT and St. Jude/Aries 700. 000014 FDA… | 1995 |
| * | — | 40 cc Grande NT™ Named without a submission number | |
| * | — | Model 940 Named without a submission number |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 8 years and passes through 2 companies; a new generation was cleared every 9 months on median.
- None of the 8 ancestors has a recall.
How does its category compare?
All DSP devicesDSP System, Balloon, Intra-Aortic And Control: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · DSP
1in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · DSP
140in 2019
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · DSP
4in 2025
Class I (47 since 2007) Class II/III not classified
Adverse event reports per year · DSP
7,422in 2025
MAUDE reports naming product code DSP, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 2 | — | 3 | 461 |
| 2008 | 0 | — | 0 | 617 |
| 2009 | 2 | — | 14 | 656 |
| 2010 | 0 | — | 8 | 1,019 |
| 2011 | 2 | — | 0 | 590 |
| 2012 | 2 | — | 3 | 490 |
| 2013 | 1 | — | 0 | 495 |
| 2014 | 0 | — | 1 | 1,738 |
| 2015 | 1 | — | 0 | 404 |
| 2016 | 0 | — | 9 (9) | 419 |
| 2017 | 3 | 73 | 0 | 2,164 |
| 2018 | 1 | — | 2 (2) | 3,331 |
| 2019 | 3 | 140 | 3 | 3,552 |
| 2020 | 2 | — | 0 | 3,393 |
| 2021 | 0 | — | 5 (3) | 4,345 |
| 2022 | 0 | — | 33 (33) | 5,113 |
| 2023 | 1 | — | 0 | 6,980 |
| 2024 | 0 | — | 1 | 7,317 |
| 2025 | 1 | — | 4 | 7,422 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The BSC/CA IABC's are indicated for use in patients with the following conditions *Refractory power failure. *Cardiogenic shock. *Unstable refractory angina. *Hemodynamically significant mechanical complications secondary to acute MI: *Ventricular septal defect. *Mitral valve regurgitation. *Papillary muscle rupture. *Cardiac support for high risk general surgical and coronary angiography/angioplasty patients. *Septic shock. The intended use of the 40 cc…
Read the full statement (213 words)
The BSC/CA IABC's are indicated for use in patients with the following conditions
*Refractory power failure.
*Cardiogenic shock.
*Unstable refractory angina.
*Hemodynamically significant mechanical complications secondary to acute MI:
*Ventricular septal defect.
*Mitral valve regurgitation.
*Papillary muscle rupture.
*Cardiac support for high risk general surgical and coronary angiography/angioplasty patients.
*Septic shock.
The intended use of the 40 cc Grande'' remains identicalto that of the currently marketed IABC's. All of the devices are intended to provide temporary circulatory support of the left ventricle through controlled mechanical displacement of a volume of blood in the aorta.
The mechanical action of the IAB catheter therapy lowers the cardiac workload by two means:
1. Systolic unloading, as noted by a reduction in the patient's systolic pressure, which provides reduced myocardial oxygen consumption (MVOZ).
2. Diastolic augmentation which provides an increase in the mean aortic pressure and leads to an improvement in systemic and coronary arterial perfusion.
Balloon pump therapy is achieved by inserting and intra-aortic balloon catheter into the descending thoracic aorta via the cammon fémoral artery. Balloon inflation is timed to occur during diastole, beginning with the aortic valve closure. The balloon remains inflated until the onset of left ventricular ejection or systole, then rapidly deflates, reducing the aortic pressure, which in turn reduces the afterload.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K974247 · printed Nov 5, 2026
Cite this page
510(k) Report. “K974247: 40 CC Grande.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K974247
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026